BridgeBio Oncology Therapeutics, Inc. Intrinsic Value
BBOT
BridgeBio Oncology Therapeutics fair value
None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for BridgeBio Oncology Therapeutics today, so there is nothing to project yet.
Peers
Pharmaceutical Preparations · Pick stocks to compare with BBOT
Held by ETFs
BBOT is in 7 US ETFs. The largest of them, with BBOT's weight in each:
State Street SPDR S&P Biotech ETFXBI0.02%of the fund
iShares Biotechnology ETFIBB0.01%of the fund
Direxion Daily S&P Biotech Bull 3X SharesLABU0.05%of the fund
- CATema Oncology ETFCANC0.48%of the fund
- BBVirtus Biotech Clinical Trials ETFBBC0.70%of the fund
Harbor Active Small Cap Growth ETFSGRW0.37%of the fund
Spot a number that looks wrong? Check it in BBOT's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BBOT
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.